Physician profile
Brian Ely
NPI 1790983302
$1,608.19
in general payments reported to CMS, 2019-2025
18 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.03 · 2020: $78.74 · 2021: $366 · 2022: $223 · 2023: $232 · 2024: $262 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901 · Education: $12.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.59 |
| Education | $12.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $259.85 | 2021 | |
| Tandem Diabetes Care, INC. | $193.97 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $193.50 | 2019-2024 | Sogroya |
| Sanofi-Aventis U.S. LLC | $181.59 | 2023-2025 | |
| Insulet Corporation | $176.22 | 2020-2025 | Omnipod |
| Biomarin Pharmaceutical INC. | $89.92 | 2022 | |
| Pfizer INC. | $83.03 | 2025 | |
| Sequel Med Tech, LLC | $82.54 | 2025 | Twiist |
| Neurocrine Biosciences, INC. | $64.88 | 2024-2025 | |
| Tolmar, INC. | $51.78 | 2023-2025 | Fensolvi |
| Dexcom, INC. | $47.86 | 2019-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $37.12 | 2023-2024 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Soleno Therapeutics, INC. | $35.99 | 2025 | Vykat Xr |
| Ascendis Pharma Endocrinology INC | $35.08 | 2022 | |
| Beta Bionics, INC. | $27.21 | 2023-2024 | Ilet Bionic Pancreas |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $17.83 | 2025 | Strensiq |
| Xeris Pharmaceuticals, INC. | $17.67 | 2021 | |
| Lilly USA, LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.